Regeneron Pharmaceuticals - 30 Year Stock Price History | REGN

Historical daily share price chart and data for Regeneron Pharmaceuticals since 1991 adjusted for splits. The latest closing stock price for Regeneron Pharmaceuticals as of September 16, 2021 is 653.18.
  • The all-time high Regeneron Pharmaceuticals stock closing price was 680.96 on September 01, 2021.
  • The Regeneron Pharmaceuticals 52-week high stock price is 686.62, which is 5.1% above the current share price.
  • The Regeneron Pharmaceuticals 52-week low stock price is 441.00, which is 32.5% below the current share price.
  • The average Regeneron Pharmaceuticals stock price for the last 52 weeks is 536.54.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Regeneron Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 533.9349 482.8600 680.9600 446.7300 653.1800 35.20%
2020 532.3580 373.3500 658.2100 336.1800 483.1100 28.66%
2019 343.5064 372.4400 439.5700 273.4600 375.4800 0.53%
2018 351.6680 382.6000 408.5100 284.6000 373.5000 -0.65%
2017 422.4830 379.7000 526.5300 340.7500 375.9600 2.42%
2016 394.5000 516.5500 519.4800 331.0500 367.0900 -32.38%
2015 498.7331 410.1600 592.4000 396.8900 542.8700 32.33%
2014 333.6675 274.5900 434.9500 267.6200 410.2500 49.05%
2013 239.8612 181.2000 316.6320 158.4200 275.2400 60.89%
2012 130.8339 56.4300 187.7400 56.4300 171.0700 208.62%
2011 51.1067 33.8200 72.1900 32.6100 55.4300 68.84%
2010 26.2129 24.6300 33.6900 20.7900 32.8300 35.77%
2009 17.7172 18.7000 24.7400 12.0500 24.1800 31.70%
2008 18.9787 23.5600 24.7500 13.3500 18.3600 -23.98%
2007 20.5494 19.8100 28.6000 13.6600 24.1500 20.33%
2006 16.1155 15.9000 24.2800 11.1200 20.0700 26.23%
2005 8.2982 9.0400 16.8300 4.6300 15.9000 72.64%
2004 10.8352 15.0500 16.7200 6.8500 9.2100 -37.39%
2003 14.7557 19.0900 22.3050 5.8800 14.7100 -20.53%
2002 18.8848 27.9200 29.3100 11.3600 18.5100 -34.27%
2001 28.3779 35.5600 39.0000 20.6000 28.1600 -20.16%
2000 27.3401 12.3100 56.5000 11.6300 35.2700 176.63%
1999 7.8169 7.9380 12.7500 5.5630 12.7500 72.88%
1998 8.1477 8.8750 10.9400 5.8750 7.3750 -13.87%
1997 9.8900 17.1300 19.3800 6.5000 8.5630 -46.88%
1996 16.2382 13.2500 24.6250 11.8750 16.1200 26.43%
1995 9.5972 3.3130 16.9400 3.3130 12.7500 325.00%
1994 7.0362 15.2500 17.2500 3.0000 3.0000 -80.65%
1993 15.5031 12.0000 21.5000 11.0000 15.5000 29.17%
1992 13.0192 18.7500 22.5000 8.0000 12.0000 -33.81%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $69.735B $8.497B
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $175.368B 54.17
Bristol Myers Squibb (BMY) United States $137.771B 9.17
Amgen (AMGN) United States $123.866B 13.41
CSL (CSLLY) Australia $102.597B 0.00
Gilead Sciences (GILD) United States $89.973B 8.70
BioNTech SE (BNTX) Germany $86.154B 18.59
Illumina (ILMN) United States $65.997B 74.98
Vertex Pharmaceuticals (VRTX) United States $48.996B 19.04
Biogen (BIIB) United States $44.592B 12.24
BeiGene (BGNE) Cayman Islands $34.845B 0.00
Genmab (GMAB) Denmark $28.151B 69.13
Seagen (SGEN) United States $27.670B 46.65
Genmab (GNMSF) Denmark $27.591B 68.97
Horizon Therapeutics Public (HZNP) Ireland $23.961B 22.71
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $22.282B 0.00
Bio-Techne Corp (TECH) United States $20.698B 93.08
Exact Sciences (EXAS) United States $17.994B 0.00
Novavax (NVAX) United States $17.303B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.550B 0.00
Repligen (RGEN) United States $16.274B 124.02
Incyte (INCY) United States $16.218B 38.45
BioMarin Pharmaceutical (BMRN) United States $14.168B 101.67
Guardant Health (GH) United States $12.865B 0.00
QIAGEN (QGEN) Netherlands $12.195B 20.65
Zai Lab (ZLAB) China $11.901B 0.00
Intellia Therapeutics (NTLA) United States $11.055B 0.00
CureVac (CVAC) Germany $10.540B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.935B 22.95
Biohaven Pharmaceutical Holding (BHVN) United States $8.894B 0.00
Ascendis Pharma (ASND) Denmark $8.873B 0.00
Mirati Therapeutics (MRTX) United States $8.677B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.417B 30.17
Acceleron Pharma (XLRN) United States $8.170B 0.00
Vir Biotechnology (VIR) United States $6.832B 0.00
Beam Therapeutics (BEAM) United States $6.775B 0.00
Sarepta Therapeutics (SRPT) United States $6.711B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.580B 0.00
Exelixis (EXEL) United States $6.449B 70.59
Denali Therapeutics (DNLI) United States $6.402B 181.48
Fate Therapeutics (FATE) United States $6.330B 0.00
Blueprint Medicines (BPMC) United States $6.076B 17.15
Halozyme Therapeutics (HALO) United States $5.871B 23.98
Legend Biotech (LEGN) United States $5.871B 0.00
NeoGenomics (NEO) United States $5.802B 786.33
Twist Bioscience (TWST) United States $5.568B 0.00
Certara (CERT) United States $5.524B 0.00
I-Mab (IMAB) China $5.243B 0.00
AbCellera Biologics (ABCL) $5.242B 0.00
Adaptive Biotechnologies (ADPT) United States $5.153B 0.00
Alkermes (ALKS) Ireland $4.951B 146.14
Arvinas (ARVN) United States $4.668B 0.00
Editas Medicine (EDIT) United States $4.116B 0.00
Reata Pharmaceuticals (RETA) United States $3.859B 0.00
Galapagos (GLPG) Belgium $3.634B 0.00
Arena Pharmaceuticals (ARNA) United States $3.609B 0.00
SpringWorks Therapeutics (SWTX) United States $3.544B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.470B 0.00
Kymera Therapeutics (KYMR) United States $3.317B 0.00
Prothena (PRTA) Ireland $3.305B 0.00
Insmed (INSM) United States $3.185B 0.00
ALX Oncology Holdings (ALXO) United States $3.154B 0.00
Emergent Biosolutions (EBS) United States $3.069B 7.40
Amicus Therapeutics (FOLD) United States $2.969B 0.00
Apellis Pharmaceuticals (APLS) United States $2.951B 0.00
Cytokinetics (CYTK) United States $2.814B 0.00
Intra-Cellular Therapies (ITCI) United States $2.723B 0.00
Heska (HSKA) United States $2.701B 517.80
ACADIA Pharmaceuticals (ACAD) United States $2.554B 0.00
Myriad Genetics (MYGN) United States $2.554B 0.00
Seer (SEER) $2.493B 0.00
Instil Bio (TIL) United States $2.476B 0.00
Celldex Therapeutics (CLDX) United States $2.473B 0.00
Morphic Holding (MORF) United States $2.442B 0.00
Arcus Biosciences (RCUS) United States $2.382B 0.00
Vericel (VCEL) United States $2.378B 283.33
Sorrento Therapeutics (SRNE) United States $2.367B 0.00
C4 Therapeutics (CCCC) United States $2.364B 0.00
Ligand Pharmaceuticals (LGND) United States $2.266B 33.14
Protagonist Therapeutics (PTGX) United States $2.210B 0.00
Atea Pharmaceuticals (AVIR) United States $2.151B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.072B 35.29
Amarin (AMRN) Ireland $2.040B 516.00
Myovant Sciences (MYOV) United Kingdom $2.010B 0.00
NGM Biopharmaceuticals (NGM) United States $1.983B 0.00
Alector (ALEC) United States $1.962B 0.00
REGENXBIO (RGNX) United States $1.924B 0.00
Revance Therapeutics (RVNC) United States $1.905B 0.00
Castle Biosciences (CSTL) United States $1.881B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.830B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.802B 0.00
Berkeley Lights (BLI) United States $1.786B 0.00
PHARMA MAR SA (PHMMF) Spain $1.737B 0.00
UniQure (QURE) Netherlands $1.676B 5.70
MorphoSys AG (MOR) Germany $1.671B 0.00
Dynavax Technologies (DVAX) United States $1.662B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.649B 0.00
Global Blood Therapeutics (GBT) United States $1.621B 0.00
Nurix Therapeutics (NRIX) United States $1.616B 0.00
Codexis (CDXS) United States $1.600B 0.00
Inovio Pharmaceuticals (INO) United States $1.592B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.563B 0.00
MaxCyte (MXCT) United States $1.541B 0.00
Zymeworks (ZYME) Canada $1.532B 0.00
Kadmon Holdings (KDMN) United States $1.517B 0.00
Ocugen (OCGN) United States $1.497B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.475B 0.00
Bionano Genomics (BNGO) United States $1.474B 0.00
Travere Therapeutics (TVTX) United States $1.429B 0.00
Genetron Holdings (GTH) China $1.420B 0.00
PureTech Health (PRTC) United States $1.418B 0.00
Zealand Pharma (ZEAL) Denmark $1.398B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.393B 0.00
Scholar Rock Holding (SRRK) United States $1.380B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.377B 0.00
Inhibrx (INBX) United States $1.372B 0.00
Sangamo Therapeutics (SGMO) United States $1.331B 0.00
Agenus (AGEN) United States $1.253B 0.00
BioAtla (BCAB) United States $1.246B 0.00
Coherus BioSciences (CHRS) United States $1.208B 0.00
Bluebird Bio (BLUE) United States $1.203B 0.00
Avid Bioservices (CDMO) United States $1.169B 238.13
MannKind (MNKD) United States $1.166B 0.00
Repare Therapeutics (RPTX) Canada $1.143B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.143B 0.00
Precigen (PGEN) United States $1.130B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.117B 0.00
RAPT THERAPTICS (RAPT) United States $1.105B 0.00
Fulcrum Therapeutics (FULC) United States $1.087B 0.00
Northwest Biotherapeutics (NWBO) United States $1.075B 0.00
ImmunityBio (IBRX) United States $1.046B 0.00
IDEAYA Biosciences (IDYA) United States $1.002B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Merus (MRUS) Netherlands $0.983B 0.00
Nkarta (NKTX) United States $0.968B 0.00
Prometheus Biosciences (RXDX) United States $0.949B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.941B 0.00
Sutro Biopharma (STRO) United States $0.922B 0.00
Immatics (IMTX) Germany $0.920B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.909B 28.17
BeyondSpring (BYSI) United States $0.898B 0.00
Avidity Biosciences (RNA) United States $0.862B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.843B 0.00
Shattuck Labs (STTK) United States $0.842B 0.00
Mesoblast (MESO) Australia $0.824B 0.00
VBI Vaccines (VBIV) United States $0.809B 0.00
Curis (CRIS) United States $0.765B 0.00
Precision BioSciences (DTIL) United States $0.741B 0.00
Cara Therapeutics (CARA) United States $0.740B 92.31
Keros Therapeutics (KROS) United States $0.728B 0.00
Amryt Pharma (AMYT) United Kingdom $0.717B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.711B 0.00
AnaptysBio (ANAB) United States $0.709B 0.00
Pliant Therapeutics (PLRX) United States $0.677B 0.00
Adagene (ADAG) China $0.665B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.656B 11.95
Mersana Therapeutics (MRSN) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Cellectis S.A (CLLS) France $0.636B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.633B 0.00
Gritstone Bio (GRTS) United States $0.632B 0.00
Ambrx Biopharma (AMAM) United States $0.629B 0.00
Pharming Group (PHAR) Netherlands $0.627B 0.00
MiMedx (MDXG) United States $0.626B 0.00
Affimed (AFMD) Germany $0.622B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.620B 0.00
Akoya Biosciences (AKYA) United States $0.617B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
Spero Therapeutics (SPRO) United States $0.596B 0.00
Bolt Biotherapeutics (BOLT) United States $0.595B 0.00
G1 THERAPEUTICS (GTHX) United States $0.590B 0.00
Seres Therapeutics (MCRB) United States $0.582B 0.00
Anika Therapeutics (ANIK) United States $0.574B 0.00
DBV Technologies S.A (DBVT) France $0.573B 0.00
MeiraGTx Holdings (MGTX) United States $0.569B 0.00
VistaGen Therapeutics (VTGN) United States $0.563B 0.00
ALBIREO PHARMA (ALBO) United States $0.563B 0.00
Vaccitech (VACC) United Kingdom $0.553B 0.00
Epizyme (EPZM) United States $0.550B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.527B 0.00
Clovis Oncology (CLVS) United States $0.527B 0.00
Inventiva S.A (IVA) France $0.522B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.501B 0.00
AC Immune SA (ACIU) Switzerland $0.495B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Selecta Biosciences (SELB) United States $0.491B 0.00
Cel-Sci (CVM) United States $0.481B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.480B 0.00
XBiotech (XBIT) United States $0.479B 0.00
Verastem (VSTM) United States $0.461B 0.00
Clene (CLNN) United States $0.457B 0.00
ChromaDex (CDXC) United States $0.455B 0.00
Bellus Health (BLU) Canada $0.454B 0.00
Innate Pharma S.A (IPHA) France $0.442B 0.00
Geron (GERN) United States $0.436B 0.00
Oncobiologics (OTLK) United States $0.424B 0.00
Compugen (CGEN) Israel $0.419B 0.00
Arbutus Biopharma (ABUS) United States $0.418B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.415B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.415B 0.00
BioDelivery Sciences (BDSI) United States $0.410B 12.61
Codiak BioSciences (CDAK) United States $0.403B 0.00
SQZ Biotechnologies (SQZ) United States $0.398B 0.00
Clearside Biomedical (CLSD) United States $0.391B 0.00
Starpharma Holdings (SPHRY) Australia $0.390B 0.00
Cue Biopharma (CUE) United States $0.382B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.381B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.371B 0.00
Athenex (ATNX) United States $0.371B 0.00
Cybin (CYBN) Canada $0.368B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.364B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.364B 0.00
ANI Pharmaceuticals (ANIP) United States $0.350B 9.54
Aeglea BioTherapeutics (AGLE) United States $0.343B 0.00
Theratechnologies (THTX) Canada $0.342B 0.00
Neoleukin Therapeutics (NLTX) United States $0.341B 0.00
Opthea (OPT) Australia $0.338B 0.00
Fortress Biotech (FBIO) United States $0.335B 0.00
Athersys (ATHX) United States $0.333B 0.00
Prima BioMed (IMMP) Australia $0.327B 0.00
Cogent Biosciences (COGT) United States $0.325B 0.00
Syros Pharmaceuticals (SYRS) United States $0.325B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Angion Biomedica (ANGN) United States $0.319B 0.00
INmune Bio (INMB) United States $0.312B 0.00
AquaBounty Technologies (AQB) United States $0.298B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.290B 0.00
Puma Biotechnology (PBYI) United States $0.284B 0.00
WAVE Life Sciences (WVE) Singapore $0.281B 0.00
XOMA (XOMA) United States $0.275B 115.81
Beyond Air (XAIR) United States $0.272B 0.00
Checkpoint Therapeutics (CKPT) United States $0.262B 0.00
Cardiff Oncology (CRDF) United States $0.259B 0.00
IBio (IBIO) United States $0.244B 0.00
Frequency Therapeutics (FREQ) United States $0.243B 0.00
Kamada (KMDA) Israel $0.239B 19.85
OVID THERAPEUTC (OVID) United States $0.235B 2.06
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
Kaleido Biosciences (KLDO) $0.229B 0.00
Adicet Bio (ACET) United States $0.225B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.224B 0.00
Adverum Biotechnologies (ADVM) United States $0.213B 0.00
Seelos Therapeutics (SEEL) United States $0.203B 0.00
NextCure (NXTC) United States $0.201B 0.00
Trevena (TRVN) United States $0.201B 0.00
Kala Pharmaceuticals (KALA) United States $0.200B 0.00
Talis Biomedical (TLIS) United States $0.193B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
SESEN BIO, INC (SESN) United States $0.183B 0.00
TELA Bio (TELA) United States $0.181B 0.00
ObsEva SA (OBSV) Switzerland $0.176B 0.00
CorMedix Inc (CRMD) United States $0.176B 0.00
GENFIT S.A (GNFT) France $0.173B 0.00
VolitionRX (VNRX) United States $0.170B 0.00
Synlogic (SYBX) United States $0.166B 0.00
Enzo Biochem (ENZ) United States $0.165B 48.57
TScan Therapeutics (TCRX) United States $0.165B 0.00
HOOKIPA Pharma (HOOK) United States $0.164B 0.00
Aptinyx (APTX) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
Galena Biopharma (SLS) United States $0.160B 0.00
ADMA Biologics Inc (ADMA) United States $0.159B 0.00
Catalyst Biosciences (CBIO) United States $0.159B 0.00
Erytech Pharma SA (ERYP) France $0.157B 0.00
LogicBio Therapeutics (LOGC) United States $0.146B 0.00
Dyadic (DYAI) United States $0.146B 0.00
Biofrontera AG (BFRA) Germany $0.145B 0.00
Vascular Biogenics (VBLT) Israel $0.145B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.145B 0.00
ATyr Pharma (LIFE) United States $0.144B 0.00
VTv Therapeutics (VTVT) United States $0.144B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.144B 0.00
Strongbridge Biopharma (SBBP) United States $0.143B 0.00
Nicox SA (NICXF) France $0.142B 0.00
PHASEBIO PHARMA (PHAS) United States $0.141B 0.00
Applied Genetic Technologies (AGTC) United States $0.139B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
Novogen (KZIA) Australia $0.135B 0.00
Purple Biotech (PPBT) Israel $0.129B 0.00
Cyclerion Therapeutics (CYCN) United States $0.127B 0.00
Abeona Therapeutics (ABEO) United States $0.126B 0.00
Evofem Biosciences (EVFM) United States $0.123B 0.00
Eton Pharmaceuticals (ETON) United States $0.123B 0.00
Orgenesis (ORGS) United States $0.122B 248.00
X4 Pharmaceuticals (XFOR) United States $0.119B 0.00
Exicure (XCUR) United States $0.119B 0.00
Yumanity Therapeutics (YMTX) United States $0.118B 0.00
Eyenovia (EYEN) United States $0.116B 0.00
Leap Therapeutics (LPTX) United States $0.115B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Voyager Therapeutics (VYGR) United States $0.114B 6.54
Viridian Therapeutics (VRDN) United States $0.114B 0.00
Entera Bio (ENTX) Israel $0.109B 0.00
Palatin Technologies (PTN) United States $0.108B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
Cocrystal Pharma (COCP) United States $0.103B 0.00
Armata Pharmaceuticals (ARMP) United States $0.097B 0.00
Pluristem Therapeutics (PSTI) Israel $0.095B 0.00
Aadi Bioscience (AADI) United States $0.090B 0.00
Celsion (CLSN) United States $0.089B 0.00
Lumos Pharma (LUMO) United States $0.088B 0.00
Aptevo Therapeutics (APVO) United States $0.084B 0.00
Adocia (ADOCY) France $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
Zosano Pharma (ZSAN) United States $0.080B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.080B 0.00
Advaxis (ADXS) United States $0.080B 0.00
Liminal BioSciences (LMNL) Canada $0.078B 0.00
Aytu BioPharma (AYTU) United States $0.077B 0.00
AEterna Zentaris (AEZS) United States $0.075B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
DiaMedica Therapeutics (DMAC) United States $0.073B 0.00
Edesa Biotech (EDSA) Canada $0.072B 0.00
Emmaus Life Sciences (EMMA) United States $0.071B 0.00
Evogene (EVGN) Israel $0.071B 0.00
Longeveron (LGVN) United States $0.070B 0.00
Celyad SA (CYAD) Belgium $0.069B 0.00
Vaccinex (VCNX) United States $0.069B 0.00
Vyant Bio (VYNT) United States $0.069B 0.00
AIkido Pharma (AIKI) United States $0.068B 0.00
ABVC BioPharma (ABVC) United States $0.067B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
Enveric Biosciences (ENVB) United States $0.057B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
AnPac Bio-Medical Science (ANPC) China $0.053B 0.00
Acorda Therapeutics (ACOR) United States $0.052B 1.08
Genetic Technologies (GENE) Australia $0.052B 0.00
Statera Biopharma (STAB) United States $0.050B 0.00
Vallon Pharmaceuticals (VLON) United States $0.049B 0.00
Forte Biosciences (FBRX) United States $0.049B 0.00
Windtree Therapeutics (WINT) United States $0.049B 0.00
ARIDIS PHARMACT (ARDS) United States $0.048B 0.00
BioCardia (BCDA) United States $0.048B 0.00
Soligenix (SNGX) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Cyclo Therapeutics (CYTH) United States $0.042B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.038B 0.00
Alimera Sciences (ALIM) United States $0.038B 0.00
Invo BioScience (INVO) United States $0.037B 0.00
Palisade Bio (PALI) United States $0.036B 0.00
Happiness Biotech Group (HAPP) China $0.035B 0.00
Timber Pharmaceuticals (TMBR) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
ZIVO Bioscience (ZIVO) United States $0.031B 0.00
Benitec Biopharma (BNTC) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
GeoVax Labs (GOVX) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.016B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00